Chemical Structure : DN1679
货号: PC-28730Not For Human Use, Lab Use Only.
DN1679 is a potent, orally bioavailable, and highly selective CDK12/13 dual degrader with DC50 of 8.8/9.8 nM, suppresses TNBC growth both in vitro and in vivo.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
DN1679 is a potent, orally bioavailable, and highly selective CDK12/13 dual degrader with DC50 of 8.8/9.8 nM, suppresses TNBC growth both in vitro and in vivo.
DN1679 exhibits undesired activity against CDK4, CDK6, and CDK9.
DN1679 significantly inhibited the proliferation of multiple TNBC cell lines, with IC50 values of 31.7 ± 1.1 nM in MDA-MB-157, 49.1 ± 2.5 nM in MDA-MB-231, and 121.4 ± 1.4 nM in MDA-MB-468 cells.
DN1679 effectively suppressed the mRNA levels of key DDR genes, including ATM, ATR, BRCA1, FANCD2, FANCI, and RAD51 in a time-dependent manner.
DN1679 demonstrates robust synergy with the PARP inhibitor olaparib in vivo, leading to significantly enhanced antitumor efficacy.
| 分子量 | 1068.12 | |
| 分子式 | C52H53F4N11O8S | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Danni Chen, et al. J Med Chem. 2026 Jan 22;69(2):1033-1048.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright